Andrew is impressive and Read the cases below Ropes

New Post Public Reply Private Reply Replies (0) Message Board
Bazinga
375
Andrew is impressive and

Read the cases below

Ropes & Gray
Biographies
Enter Keywords
Submit
MENU

Submit

Home» Biographies» Radsch, Andrew

ANDREW RADSCH
COUNSEL
radsch-andrew-300
CONTACT
Andrew.Radsch@ropesgray.com
T+1 650 617 4763 Silicon Valley
T+1 415 315 2318 San Francisco
Add to Contacts (vCard)

EDUCATION
ADMISSIONS / QUALIFICATIONS


AWARDS
Andrew Radsch is an experienced trial lawyer in Ropes & Gray’s intellectual property litigation group, where he counsels clients on their most business-critical patent litigation and trade secret disputes, in both district courts and the ITC. Andrew, who has been selected by his peers as a Super Lawyers Rising Star in IP Litigation, has counseled companies in a wide range of industries and technologies, including computer software and hardware, consumer electronics, wireless communications, semiconductor manufacturing, pharmaceuticals, medical devices, and consumer care products. In addition to his trial work, Andrew regularly advises companies on offensive and defensive IP strategies.

Andrew has experience at all stages of litigation, from pre-suit investigation and licensing negotiations, through trial and appeal. Andrew’s trial experience includes two week-long jury trials, and a 19-day bench trial. In addition to his first chair trial experience, Andrew has played a key role in developing and executing on case strategy and has substantial experience crafting winning briefs and arguing dispositive and non-dispositive motions.

In addition, Andrew has substantial experience in contested Section 1782 proceedings seeking discovery in aid of foreign patent litigations.

Andrew also maintains an active pro bono practice. His matters include leading a team in obtaining a restraining order and child custody for a domestic violence victim after several hearings; obtaining asylum for a Chadian refugee from political violence; and assisting individual artists in protecting their intellectual property rights.

During law school, Andrew was an extern for the Honorable Deborah A. Batts at the United States District Court for the Southern District of New York.

EXPERIENCE

Rovi v. Comcast et al. (E.D. Tex. / ITC) – Represent Rovi in district court and ITC actions involving interactive program guides and related hardware and software.

Godo Kaisha IP Bridge 1 v. Broadcom Ltd et al. (E.D. Tex.) – Represented IP Bridge in in a six-patent suit involving semiconductors and microprocessors. Obtained highly favorable settlement for IP Bridge just weeks before trial and following the Court’s denial of Broadcom’s summary judgment motion that sought to limit the scope of potential infringement and damages.

Medtronic MiniMed, Inc. v. Nova Biomedical Corp. et al. (C.D. Cal.): Represented Nova in a suit with allegations of misappropriation of trade secrets, breach of contract, and unfair competition relating to blood glucose meters. After a three-week jury trial in Los Angeles federal court, the jury unanimously found for Nova on all counts.

Intellectual Ventures I LLC et al. v. A Major Japanese Consumer Electronics Company (D. Del.) – Represented a major Japanese electronics manufacturer in a multi-patent infringement litigation involving semiconductors and various features of digital cameras. Obtained highly favorable settlement shortly after the Court issued its Markman order.

Shelbyzyme LLC v. Genzyme Corp. (D. Del.) – Represented Genzyme in patent infringement action concerning Genzyme’s life-saving drug, Fabrazyme®. Obtained favorable settlement after a week-long jury trial and an order compelling Shelbyzyme to produce attorney-client privileged communications based on the crime fraud exception, and shortly before bench trial on Genzyme’s equitable defenses.

Agranat Inc. v. A Leading Global Information Technology Company: Represented a leading global information technology company in a patent infringement action involving embedded web server technology, obtaining highly favorable settlement immediately after obtaining damaging admissions during expert depositions.

Penovia LLC v. A Leading Global Information Technology Company (E.D. Tex.) – Represented a leading global information technology company in a patent litigation matter related to office machine monitoring systems and obtained extremely favorable settlement before answering complaint.

Bayer Healthcare Pharmaceuticals v. Baxter Healthcare and Bayer Healthcare Pharmaceuticals v. Nektar Therapeutics: Represented Bayer in connection with discovery in aid of a German litigation under 28 U.S.C. Section 1782 concerning recombinant Factor VIII for hemophiliacs. Successfully obtained substantial discovery, defeating numerous motions to quash and to limit discovery.

Clean Energy Management Solutions v. SmartThings, Inc. (E.D. Tex.) – As litigation counsel for SmartThings, obtained early dismissal in an infringement suit on a patent asserted against “Internet of Things” products.

NuVasive, Inc. v. Cadwell Labs. (S.D. Cal.) – Obtained favorable settlement on behalf of client in patent suit relating to intraoperative monitoring equipment.

PerkinElmer v. Bruker Corp. (N.D. Cal.) – Obtained favorable settlement on behalf of client after successfully defeating defendant’s motion to dismiss based on claim and issue preclusion

AstraZeneca LP et al v. Watson Labs., Breath Ltd., Apotex Corp and Apotex Inc., and Sandoz, Inc. (D.N.J.) – Represented AstraZeneca in 19-day bench trial involving pediatric asthma drug, PULMICORT RESPULES®, and patents concerning methods of treatment and sterilized compositions.

Suzanne Jaffe Stillman v. Bayer HealthCare LLC, et al. (C.D. Cal.): Represented Bayer in a patent infringement action concerning dietary supplements containing fiber, water and “encapsulated” probiotics. The plaintiff voluntarily dismissed with prejudice all direct infringement claims after the court granted our motion to dismiss with prejudice all claims for indirect infringement.

LG Electronics, U.S.A., et al. v. Whirlpool Corp., et al. (D.N.J.): Represented LG in a multi-patent infringement suit related to various mechanical features of high-end refrigerators. The case was settled on favorable terms in September 2012.
Pall Corp. v. Entegris Inc. (E.D.N.Y.): Represented Entegris in a patent infringement suit related to structure and packaging of filters used in the manufacture of semiconductors. The case was favorably settled in January 2011.
PUBLICATIONS

Cited, “Comcast, Manufacturers Infringe 2 Rovi Patents: ITC Judge,” Law360 (May 31, 2017)
PRACTICES
Litigation
Intellectual Property
Trade Secret Litigation
Trademark & Related IP Litigation
Intellectual Property Litigation
Copyright Infringement
Patent Litigation
INDUSTRIES
NEWS


LEGAL NOTICES / SITE MAP
Copyright © 2017 Ropes & Gray LLP. All rights reserved. Attorney advertising. Prior results do not guarantee a similar outcome.
Ropes & Gray
Biographies
E

Zerify Inc (ZRFY) Stock Research Links

ZRFY Board Company Profile Buy Rating Time & Sales News Filings Financials
All the information I post here is my opinion and is not advice to buy or sell a stock..Do your DD and research...GLTA
Scroll down for more posts ▼

Top 10 Most Recent News Articles

A. O. Smith Reports Q3 2026: A Strategic Shift

Updated Category News Views 57

A. O. Smith Navigates Change in Third Quarter 2026 It's been a gritty third quarter for A. O. Smith, as the company maneuvers through domestic challenges and crafts a strategic future with international tweaks. They've hammered out $941 million in sales but found themselves grappling with net earnings dipping to $126 million, or $0.93 per diluted share, a mere blip from...

Continue Reading
BioMarin Strikes Deal for New Fabry Disease Therapy

Updated Category News Views 35

BioMarin's Latest Moves in Rare Disease Therapies Now here's a plot twist in the biotechnology landscape. BioMarin Pharmaceutical Inc. (NASDAQ: BMRN) just did what they do best—snagging rights to a promising enzyme therapy aimed at turning the tide for Fabry disease. In a deal that spoke volumes about their intentions, BioMarin is forking over a cool $70 million upfront...

Continue Reading
Torchy's Tacos Reintroduces Nookies: Fan Favorite Returns

Updated Category News Views 78

A Sweet Return to the Menu In the wild world of fast-casual dining, bringing back a beloved menu item is like striking gold. Torchy's Tacos is doing just that by reintroducing their legendary Nookies—fried chocolate chip cookie dough bites that have been a crowd favorite since 2008. After a two-year hiatus, these treats are back, complete with a cinnamon-sugar twist to...

Continue Reading
Broadway.com Instagram Reaches Million Followers Milestone

Updated Category News Views 54

Broadway.com's Instagram Ascends to Iconic Status There it is, folks—Broadway.com's Instagram just threw down the gauntlet with a clean, million-follower milestone. That's right, a hefty chunk of people now have a front-row seat to Broadway's electric world, straight from their phones. If you're a Broadway buff or just a casual admirer of glitz and glam, these numbers...

Continue Reading
LanguageLine AI App Earns Vizient Technology Kudos

Updated Category News Views 57

Tech Talk: LanguageLine's AI App Gains Important Recognition Diving headfirst into the chaotic world of healthcare, LanguageLine's AI Translation App earned a standout accolade. Just announced, it's snagged the Innovative Technology Designation from Vizient, the heavyweight champ in healthcare performance improvement. On the scene since the end of October, they rolled the...

Continue Reading
Landstar Faces Legal Storm Post Earnings Miss

Updated Category News Views 17

Landstar's Earnings Misstep Sends Shockwaves Alright, let's talk about this snafu at Landstar (NASDAQ: LSTR). They were supposed to deliver an earnings sheet that's all roses, but instead, we got a couple of thorns. Analysts were expecting them to strike gold with EPS numbers between $1.62 to $1.67. What we got? A measly $1.42. Not exactly the shiny haul we were led to...

Continue Reading
Quanta Services Reports Record Q3 2026 Earnings

Updated Category News Views 120

Quanta Services Smashes Q3 2026 Expectations If you're a stakeholder in Quanta Services, you'd probably be dancing in the aisles right now. This company just posted off-the-charts numbers for the third quarter of 2026. We're talking revenues of $12 billion—a staggering leap from $7.63 billion the same quarter last year. Explosive Earnings and Strong Backlog The star of...

Continue Reading
Marvix AI & Unlimited Systems Forge Game-Changing Partnership

Updated Category News Views 44

Two Forces Colliding in Specialty Care There's a new dynamic duo in town, and they're set to shake up the specialty practice world. Marvix AI, with its cutting-edge clinical documentation AI, and Unlimited Systems, a powerhouse in revenue cycle management, have teamed up in a way that promises to streamline and optimize the specialty practice workflow substantially....

Continue Reading
Service Pros Adds Windshield Repair to Lineup

Updated Category News Views 27

Revving Up the Service Engine Alright, folks, buckle up because Service Pros Auto Glass, our local go-to for windshield replacements, is cranking up their game. They're stepping into the windshield repair arena across Florida and South Carolina, aiming to save you a buck and keep you safe behind the wheel. That's a double win if you ask me. A Closer Look at the Details...

Continue Reading
Thunderly Bags Davey Awards for Creative Franchise Videos

Updated Category News Views 87

Big Wins from Humble Beginnings Ever notice how some small outfits have a knack for punching above their weight? Thunderly, a Dallas-based marketing agency, is a shining example of that. They've just snagged two Silver Awards at the 22nd Annual Davey Awards—and it’s stirring up talk across the sector. Winning a Davey isn’t child's play; it’s about small teams...

Continue Reading

Top 5 Most Recently Viewed Articles

Former U.S. Security Advisor Voices Concerns on Taiwan's Safety

Updated Category News Views 171

Former U.S. Security Advisor Highlights Taiwan's Risks John Bolton, the former U.S. national security adviser, has been vocal about his worries regarding the future of Taiwan if Donald Trump manages to reclaim the presidency in the forthcoming elections. Concerns Raised About Taiwan's Presidency During a recent BBC HARDtalk interview, Bolton shared his apprehensions about...

Continue Reading
2ONE Labs Fights Back Against Trademark Infringement in Courts

Updated Category News Views 263

Legal Battle Over Trademark Rights In a significant legal development, 2ONE Labs and Performance Plus Marketing have initiated legal proceedings against Imperial Brands for trademark infringement related to their Zone nicotine pouch product. This lawsuit aims to protect the integrity of the 2ONE brand within the competitive nicotine pouch market. The Allegations of...

Continue Reading
Growth and Innovation in the Biodefense Market Sector

Updated Category News Views 163

Overview of the Biodefense Market Expansion The global biodefense market is poised for substantial growth, projected to reach USD 22.8 billion by 2030, underpinned by a compound annual growth rate (CAGR) of 5%. Recently, incidents of infectious diseases have underscored the need for robust biodefense strategies, prompting governmental and health organizations to bolster...

Continue Reading
Dayforce Set to Release Q3 2024 Results and Attend Events

Updated Category News Views 100

Dayforce Readies for Third Quarter 2024 Performance Announcement In a significant announcement from Dayforce, Inc. (NYSE:DAY) (TSX:DAY), the global leader in human capital management (HCM), the company has scheduled the release of its financial results for the third quarter of 2024. This pivotal event is set to unfold before the regular market trading begins on Wednesday,...

Continue Reading
Cracker Barrel: A Hidden Opportunity for Savvy Investors

Updated Category News Views 141

Cracker Barrel's Resilience Amid Challenges After battling years of challenges like the impact of the pandemic, inflation pressures, and shifting consumer behaviors, Cracker Barrel (NASDAQ: CBRL) is showing signs of recovery. Despite lackluster FQ4 and full-year 2024 results, expectations are rising for better performance as we move into F2025. While there is still a way...

Continue Reading